应用EVITA模型对甘肃省水痘疫苗接种的经济学评价
张晓曙;王晓玲;李慧
【期刊名称】《中国卫生经济》 【年(卷),期】2012(031)003
【摘要】Objective: To analyze cost-benefit of Varicella Attenuated Live Vaccine (VarV) immunization in Cansu Province, for varicella prevention and control in the furture. Methods: Three different strategies versus no vaccination were performed. Strategy I : Routine Immunization only (one dose in toddlers 1-1.5 years) ; Strategy II: Routine plus Catching-up Immunization (one dose was caught up in adolescents of 12 years) ; Strategy IE: Routine plus Supplementary Immunization Activities in children of 2-15 years, EVITA model is used to evaluate cost-benefit and calculate incidence, economical burden, BCR and NPV of Varicella in future 15 years. Result: Accumulated 5 301 764 cases will occur in no vaccination people; Strategy I : BCR=0.744, NPV =-0.98; Strategy II: BCR=0.595, NPV =-6.19; Strategy 1 : BCR=1.518, NPV =0.49. BCR of Strategy! Is highest and BCR>l&NPV>0, so cost-benefit of Strategy IS is the best. Conclusion: Routine plus Supplementary Immunization Activities in children 2-15 years is the best for Varicella control.%目的:对甘肃省水痘疫苗接种进行成本效益分析,为今后制定水痘防控策略提供参考依据.方法:设定三种免疫策略,即未予以免疫接种、策略Ⅰ常规免疫( l岁时接种1剂次水痘疫苗)、策略Ⅱ常规免疫+加强免疫(1岁和12岁各接种1剂次水痘疫苗)、
应用EVITA模型对甘肃省水痘疫苗接种的经济学评价
